SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-17-032535
Filing Date
2017-06-14
Accepted
2017-06-14 16:31:41
Documents
48
Period of Report
2017-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q v468370_10q.htm 10-Q 573031
2 EXHIBIT 10.2 v468370_ex10-2.htm EX-10.2 70870
3 EXHIBIT 31.1 v468370_ex31-1.htm EX-31.1 9993
4 EXHIBIT 31.2 v468370_ex31-2.htm EX-31.2 9993
5 EXHIBIT 32.1 v468370_ex32-1.htm EX-32.1 4091
6 EXHIBIT 32.2 v468370_ex32-2.htm EX-32.2 4119
  Complete submission text file 0001144204-17-032535.txt   4310822

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE opnt-20170430.xml EX-101.INS 950565
8 XBRL SCHEMA FILE opnt-20170430.xsd EX-101.SCH 35864
9 XBRL CALCULATION FILE opnt-20170430_cal.xml EX-101.CAL 24765
10 XBRL DEFINITION FILE opnt-20170430_def.xml EX-101.DEF 256179
11 XBRL LABEL FILE opnt-20170430_lab.xml EX-101.LAB 298394
12 XBRL PRESENTATION FILE opnt-20170430_pre.xml EX-101.PRE 286114
Mailing Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022
Business Address 445 PARK AVENUE 9TH FLOOR NEW YORK NY 10022 212-829-5546
OPIANT PHARMACEUTICALS, INC. (Filer) CIK: 0001385508 (see all company filings)

IRS No.: 000000000 | State of Incorp.: NV | Fiscal Year End: 0731
Type: 10-Q | Act: 34 | File No.: 000-55330 | Film No.: 17911494
SIC: 1000 Metal Mining